EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tetrandrine upregulates HTR1D to attenuate mesangial cell pathological injury in IgA nephropathy: A bioinformatics and machine learning-based study

Li-hua Luo, Dehui Liu, Fei Tan, Zhiwei Guo, Juan Peng, Yicai Wu, Xuebing Zhang, Zi-Jie Wei

Letters in Drug Design & Discovery · 2026-11 · 100672

DOI: 10.1016/j.lddd.2026.100672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-11. Verfasst von Li-hua Luo und 7 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Luo, L., Liu, D., Tan, F., Guo, Z., Peng, J., Wu, Y., Zhang, X., & Wei, Z. (2026). Tetrandrine upregulates HTR1D to attenuate mesangial cell pathological injury in IgA nephropathy: A bioinformatics and machine learning-based study. Letters in Drug Design & Discovery, 100672. https://doi.org/10.1016/j.lddd.2026.100672

Vancouver

Luo L, Liu D, Tan F, Guo Z, Peng J, Wu Y, et al. Tetrandrine upregulates HTR1D to attenuate mesangial cell pathological injury in IgA nephropathy: A bioinformatics and machine learning-based study. Letters in Drug Design & Discovery. 2026:100672. doi:10.1016/j.lddd.2026.100672

BibTeX
@article{Luo2026,
  author = {Luo, Li-hua and Liu, Dehui and Tan, Fei and Guo, Zhiwei and Peng, Juan and Wu, Yicai and Zhang, Xuebing and Wei, Zi-Jie},
  title = {Tetrandrine upregulates HTR1D to attenuate mesangial cell pathological injury in IgA nephropathy: A bioinformatics and machine learning-based study},
  journal = {Letters in Drug Design & Discovery},
  year = {2026},
  pages = {100672},
  doi = {10.1016/j.lddd.2026.100672}
}
Kostenlos starten →